A consortium led by China’s Anbang Insurance Group that was vying to take over Starwood Hotels & Resorts Worldwide has withdrawn its $14 billion bid for the company.
In a statement, it cited "various market considerations" for the decision. This comes only two weeks after Starwood terminated a prior agreement with Marriott in favor of Anbang's initial $13.1 billion...
Black Sesame Technologies, a China-based chipmaker specializing in autonomous driving applications, has closed a Series C extension led by SummitView Capital. This brings the size of the overall round to USD 500m.
Japanese lower middle-market private equity firm J-Star has made an investment of undisclosed size in air cargo transportation and courier services provider Score Japan Holdings.
Gaorong Capital and Tsing Song Capital have led a CNY 500m (USD 74m) Series C for IntellectiveBio, a China-based contract development and manufacturing organisation (CDMO).
Morningside Venture Capital has teamed up with Kingray Capital, Trinity Innovation Fund, TigerYeah Capital, and FountainBridge Capital to provide USD 20m in angel and pre-Series A funding for Epigenic Therapeutics, a China-based gene editing specialist.